Showing results (6591-6600 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|November 16, 2006
Vaccine development for Alzheimer's diseaseKevin A Dasilva, Isabelle Aubert, JoAnne McLaurinCurrent Pharmaceutical Design|November 16, 2006
The development of preventives and therapeutics for Alzheimer's disease that inhibit the formation of beta-amyloid fibrils (fAbeta), as well as destabilize preformed fAbetaKenjiro Ono, Hironobu Naiki, Masahito YamadaCurrent Pharmaceutical Design|November 16, 2006
Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitorsAna Castro, Ana MartinezCurrent Pharmaceutical Design|November 15, 2006
Protein NMR-based screening in drug discoveryE R Zartler, M J ShapiroCurrent Pharmaceutical Design|November 15, 2006
CRF1 receptors as a therapeutic target for irritable bowel syndromeV Martinez, Y TachéCurrent Pharmaceutical Design|July 20, 2005
Is Hyperhomocyst(e)inemia a humoral predictor of coronary heart disease?A Virdis, L Ghiadoni, D Versari, et al.Current Pharmaceutical Design|July 20, 2005
Modulation of collagen turnover in cardiovascular diseaseJ A Rodriguez-Feo, J P G Sluijter, D P V de Kleijn, et al.Current Pharmaceutical Design|April 28, 2005
A mechanistic approach to anticancer therapy: targeting the cell cycle with histone deacetylase inhibitorsC N Mork, D V Faller, R A SpanjaardCurrent Pharmaceutical Design|April 28, 2005
Targeting telomerase by antisense-based approaches: perspectives for new anti-cancer therapiesM Folini, N ZaffaroniPageof 1,008